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Abstract 
This study aims to reveal the strategies followed in the pharmaceutical industry, their ethical aspect and the 
image effect of the pharmaceutical companies on doctors’ prescribing habits.  The image of pharmaceutical 
companies, their contact with stakeholders in the sector, the strategies they follow, their representatives’ and 
managers’ honesty and reliability are seen vital for the doctor and the pharmacists called on. Besides, due to the 
competition in the pharmaceutical industry, promoting strategies have become crucial. It is important to take the 
ethical aspect into consideration in this process. 
In the study, frequency analysis is conducted. The data is collected from doctors, pharmacists, managers and 
representatives in pharmaceutical companies working in the four different cities in Turkey. 
Results of the study reveal that; attention-grabbing small promotional items are the most frequently used 
promoting tools;  pharmaceutical presentation is one of the most important promoting strategies that companies 
consider its ethical aspect in their marketing activities; drug samples are used by the patient; medical training is 
important for all the stakeholders in the industry; companies are giving more importance to promoting activities; 
goal-oriented marketing trends are rising; public relations enable the communication between the stakeholders; 
patient-centred view plays role in determining the promoting strategies; professionalism and honesty of the 
managers & representatives, and also the image of the company play role in doctors’ prescribing habits. 
Keywords: Pharmaceutical industry, promoting, ethics, marketing strategies.   
 
1.Introduction 
This study aims to evaluate the promotion strategies in pharmaceutical marketing in terms of doctors, medical 
representatives, pharmacists and company managers; the ethical aspect of these strategies; the effect of 
perceptions about pharmaceutical companies and their employees on the patient’s treatment process; the 
companies’ effect on the brand value. 
Regarding the aim of the study, the data is gathered from 323 participations in the sector in four different cities 
in Turkey. According to the doctors, medical representatives, pharmacists and company managers, promotion 
strategies in pharmaceutical marketing, their ethical aspect and the effect of the communication between the 
pharmaceutical company and the doctor on the treatment process and the development of brand value are tested 
by frequency analysis. 
The study consists of five parts. In the first part of the study, the problem – whether the promotion strategies in 
pharmaceutical marketing, their ethical aspect, perceptions on the pharmaceutical company and its employees 
effect the treatment process and brand value is given. In the second part, pharmaceutical marketing, promotions, 
and ethical aspect is given. In the third part, research methodology is given; in the fourth part, research analysis 
is given and the last part results and suggestions are given. 
 
3.Literature Analysis 
2.1. Promotion Strategies of Pharmaceutical Marketing 
In pharmaceutical marketing, the first stakeholder is medical representatives. They represent their companies 
outdoors. They do not have any differences from other sales representatives; they give elaborate demonstrations 
on their company products to doctors, pharmacists and to those any other concerned by visiting them, they 
provide free samples of the products and give information on what aspect this product is superior to the others. 
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However, doctors, one of the stakeholders in pharmaceutical marketing, do not see the representatives as the 
source of information even though they trust the information that representatives share with them. Doctors, 
generally prefer keeping up-to-date with health care and pharmaceutical subjects via medical journals, scientific 
publications and by word of mouth. Customers, as another stakeholder, are the people who buy the products of 
pharmaceutical companies but have lack of information on the drug, so seeing the doctor and the pharmacist as 
the assistant during the drug sale. Wholesalers and retailers are the other parties who provide the drug flow 
between pharmaceutical companies and customers. These parties control drug stocks by tracking the drug sales 
from prescriptions and provide a rational drug flow through distribution channels. 
Importers providing products of international pharmaceutical companies to different markets are also important 
stakeholders. In pharmaceutical sector, key idea leaders can be accepted as doctors  who can affect other doctors 
due to their studies and success they obtain in a field. Treatment process they follow and drugs they use are 
followed by their co-workers. Another stakeholder in pharmaceutical marketing is pharmaceutical companies. 
Pharmaceutical companies are the stakeholders that work to improve life quality by offering products and related 
marketing activity (Sharma, 2013, p.66-87).  
Pharmaceutical companies apply to various promotion strategies to activate sales within the marketing activity. 
In pharmaceutical marketing, promotion is a marketing effort which necessitates important sources. Promotion 
suggests an incentive to purchase products. While consumer promotion includes samples, coupons, cash money 
returns offerings, reduced prices, presents, free testing, warranties, selling point exposions and exhibitions; trade 
promotion includes reduced prices, advertisements, exposition expenses, and free goods. Business and sales 
promotion includes commercial exhibitions, congresses, competitions for sales representatives and social 
advertisements (Kotler, 2000, p.597). The use of  promotion provides brand and product awareness, creates 
brand addiction, encourages consumers to buy the product again, expands the market, diversifies from 
opponents, provides value for consumers, focuses on more stock amounts by encouraging distribution channels, 
convinces to try the new product or the improved product again by costumers, creates cooperation with retailers 
and develops a strategy against the promotion activities of opponents (Erdoğan, 2014: 513; Ünüsan ve Sezgin, 
2007: 285). 
In pharmaceutical marketing; promotions should put forth results of clinical trials correctly and objectively, 
reflect obtained evidences; it should not contain wrong information and be deceptive. Promotions comparing 
products, the results of published scientific studies should be shown. Pharmaceutical companies should take 
ethical standardizations into consideration. In promotion strategy, it is injurious for reputation of company and 
medicine industry (IFPA,2013, p.1-8). In promotion strategies of pharmaceutical companies, being difference 
between promised service and presented service causes falling of customer’s satisfaction level and injury of 
confidence to pharmaceutical company (Erdem, 2007 p.115; Fabien,1997 p.206). 
Pharmaceutical companies makes various clinical trials to put forth the effectiveness and reliability of medicines. 
Doctors have positive or negative verdicts about pharmaceutical based on obtained results in consequence of 
using a prepared sample for new medicines by patients. If during treatment process, positive results could be get 
depending upon using of new pharmaceutical sample, results of market tests of pharmaceuticals are dedicated to 
be successful. Subsequently, in distribution channels to be commercial of these pharmaceutical of process starts 
and distribution of these pharmaceuticals is condensational. After this process, sales team of pharmaceutical 
company plan promotion activities towards these medicines and they come into effect with starting doctor 
visiting extensively. 
In product life of pharmaceuticals periods, to be different from others of promotion strategies are seen. In 
introduction period; they concentrate on idea leader’s opinions, brochures, clinical trials, seminars, panel 
discussions, advertisement on medical media, expensive presents and sponsors. And a lot of examples are 
presented about medicine test in this period. In development period; they concentrate on advertisements in which 
health officers make explanations about results, reminder brochures, reminder presents and sponsorship. In 
matureness period; they front to patients which uses occurred recipes by specific medicines during long 
treatment process, they concentrate on reminder process and present. Also, they focus on presenting more 
examples depending on request. In declension period; promotions are also intended for promotion for market 
share as much as possible (Ahmed,Sattar,Parmar,2014,p.681-686). 
Promotions are practiced to representatives by pharmaceutical companies are intended for increasing sales 
figures in areas that these employees are responsible. Although customers are aware at promotion strategies of 
medicine companies, they cannot understand effects on them completely ( Sharma,2013,p.66-87). Generally; 
promotions are presented by pharmaceutical companies are seen as visits,encourement,presents financing of 
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particapation to conference,travelling and provision of free pharmaceutical samples. In clinical strategies, 
effective creating of promotion activities are seen individually besides admission of doctor’s responses from 
promotion individually (Katz vd.,2003,p.448). 
Analysis of marketing activities of pharmaceutical companies can be explained within patient treatment and 
effect on the medical researches. This marketing activities can reverberate patients negatively. Doctor-oriented 
promotions can be evaluated as a marketing activities which can damage to patients. Because  they defend that 
promotion applications of pharmaceutical companies affect involuntarily doctors  in the process of recipe 
preparation. In this situation, patient faces with risk in his/her health. Additionally; because of promotions are 
presented to doctors writing high price pharmaceutical on the recipe does not provide any healing on patient’s 
health quality and also patient must pay more money (Chiu,2005,p.89-94). 
Presentations  presented to doctors by pharmaceutical companies provide development of relations between two 
contractors. Yet, when  pharmaceutical promotions cause tendency of doctors to the specific way, doctors are 
perceived arrantly by public an public funding (public money) is exploited. Also medical profession can come up 
against risk of losing to patients and public. Doctors should earn trust of patients, they should have reputation on 
patient’s eyes and they should run the best treatment for their patients. In this process, doctors can determine 
treatment process and pharmaceutical which they use in this process with effect of promotions of pharmaceutical 
companies but this situation creates distrust on patients and it causes injury relations between patient and doctor ( 
Jain,2007,p.4). 
In pharmaceutical promotions, approaches which are not ethic can be followed. Suggesting wrong and incorrect 
claims about pharmaceuticals, deliberately hiding side effect and contained risks of medicine, ignoring to be 
health-oriented, using promotions which are pharmaceutical sales increasing-oriented are evaluated as moral 
problems in pharmaceutical promotions. These applications can cause improperly to use pharmaceutical of 
patients and coming up against risks which can be fatal. Therefore, these strategies ignore developed informing 
services of medicine management to provide consciousness and increase about health and then immoral 
pharmaceutical promotions strategies causes negative results with regard to patients health and safety. On the 
other hand; most of doctors do not see promotion activities ethic problem and among doctors,evaluation 
differences are identified according as value and kind of presents are presented as promotion (Ahmed vd. 
2011,p.215-221). 
Wazana asserts that pharmaceutical managements spend a lot of money for promotions in every year, endowed 
presents within promotion are efficient on prepared recipe  and these expenditures increase health expenses 
(Wazana,2000,p.373-379). Gibbons vd. puts forward that patients compared to doctors think that presents are 
more efficient on recipe preparation and they do not approve presents in Gibbons’ work in which difference of 
perspectives of patients and doctors intended for presents are presented as promotion in pharmaceutical sector. 
Most of patients joining this studying do not approve this kind of presents because patients think that presents 
are effective on prepared recipes. This result in work, patients can be effective on perspective to medical 
profession and perceptions of patients intended for this profession front to negative point (Gibbons 
vd.,1998,p.151-154). Cinaver’s work in which he evaluates marketing ways of pharmaceutical companies 
emphasizes doctors learning information about new pharmaceutical from medicine representative accept new 
medicine as a new progress, they prefer more  this medicine and they give more place on recipe compared to 
other doctors. Also, depending on doctor’s meetings with medicine representatives and increasing of confidence 
level between them, doctors’ prescription rate increases, prepared recipes are affected by presents which are 
taken by doctors. Accordingly, this situation creates an idea on patient’s mind that it affects treatment quality and 
cost (Cinaver,2014,p.33-39). 
On the other hand Rosenthal vd. puts forth that promotions doing in health care services do not cause exhibition 
of positive attitude to specific medicines by doctors or doctors do not make impression about giving place to 
unsuitable pharmaceutical on prepare for treatment of patient. Also, he asserts that advertisements which are for 
patients are important and these success of advertisements are observed in increased sales. Effects of 
advertisements which are made directly to customers depend how customers perceive these advertisements. In 
this work; thanks to advertisements, a thumping majority of customers are aware recipe pharmaceuticals and 
they discuss with their doctors about pharmaceuticals. Even if advertisements are not related with recipe 
pharmaceutical substitute doctor-oriented promotion studies, day after day more using is emphasized. Also, 
advertisements ensure customer’s acquisition of knowledge about pharmaceutical and its price and it explains 
that these advertisements help for joining more consciously for process in determination for patient the most 
suitable way (Rosenthal,2002,p.498-205). 
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3. Research Methodology 
Pharmaceutical marketing is in interaction with many other stakeholders. Tendencies in pharmaceutical 
marketing, promotion strategies and the ethical aspect of these activities are gaining more significance. 
Furthermore, perceptions on pharmaceutical companies and their employees are significant for the brand value in 
pharmaceutical marketing (Gupta, P., Udupa, A., 2011:1-8; Lakdawala, H.M., 2003:25-33). 
Regarding the aim of this study, the data is gathered from 323 participations - doctors, medical representatives, 
pharmacists and company managers- in one month in four different cities in Turkey by using convenience 
sampling.  
The responses given to the questionnaire are analyzed by using SPSS (Statiscal Package for Social Science) 15.0 
for Windows. In data analysis, the participants’ demographic characteristics, their responses to the statements in 
the questionnaire are analyzed with frequency analysis and percent value statistics. 
 
4. Research findings 
 
4.1. Research Findings on the Participants’ Demographic Variables 
 
Table 1. Demographic Variables of the Participants 
 
Demographic Variables 
Participants 
Frequency % 
Occupation  
Doctor 87 26,9 
Medical Representative 126 39,0 
Pharmacist 72 22,3 
Company Manager 38 11,8 
Total 323 100 
Age  
21-35 174 53,9 
36-50 137 42,4 
51 and above 12 3,7 
Total 323 100 
Working period 
1-10 years 186 57,6 
11-20 years 105 32,5 
21-30 years 31 9,6 
31-40 years 1 0,3 
Total 323 100 
 
In Table 1, research findings on the participants’ demographic variables are given. As it is shown in Table 1, 
%26,9 of the participants are doctors, %39 of them are medical representatives, %22,3 is pharmacists and %11,8 
is company managers. Besides, %53,9 is between 21-35 years of age, %42,4 is between 36-50 and %3,7 is 51 
and above. %57,6 of the participants have been working for 1-10 years, %32,5 has a period of 11-20 years, %9,6 
has 21-30 years and %0,3 has 31-40 years in the sector. 
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4.2. Research Findings on the Participants’ about Drug Marketing 
Table 2. The Most Common Promoting Tools 
 
In Table 2, the rates of the promoting tools in pharmaceutical marketing are shown. While doctors, medical 
representatives and company managers choose the “remarkable promoting  products” as the mostly used 
products, pharmacists choose the “gifts”.  
Table 3. Factors on Drug Recommendation 
 
In Table 3, the most important factors on drug recommendation are shown. Doctors and representatives choose 
“recent literature research” as the most important factor on drug recommendation whereas pharmacists choose 
personal relations and company managers choose “evaluation on the drug brand”. 
Table 4. Resource Allocation for Marketing 
 
 
 
 
 
 
 
 
 
 
Table 4 shows the tendencies of resource allocation for marketing efforts. Doctors and pharmacists are 
undecided about the increasing resource allocation of pharmaceutical companies, but medical representatives and 
company managers disagree with the statement. 
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Doctor 21,8 9,2 41,4 - 27,6 
M.Representative 12,7 9,5 50,8 2,4 24,6 
Pharmacist 13,9 37,5 31,9 2,8 13,9 
Company Manager 18,4 2,6 55,3 2,6 21,1 
The most important 
factor on drug 
recommendation  
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Doctor 4,6 - 8 8 79,3 
M.Representative 7,1 2,4 34,9 14,3 41,3 
Pharmacist 5,6 29,2 38,9 12,5 13,9 
Company Manager 2,6 7,9 21,1 57,9 10,5 
Statement: 
 
Pharmaceutical 
companies are 
allocating more and 
more resource for 
marketing efforts. 
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Doctor 12,6 18,4 34,5 21,8 12,6 
M.Representative 9,5 30,2 27 23,8 9,5 
Pharmacist 8,3 20,8 38,9 22,2 9,7 
Company Manager 2,6 57,9 13,2 18,4 7,9 
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Table 5. Ethics in Marketing Activities 
 
 
 
 
 
 
 
 
 
 
In Table 5, opinions on ethics of pharmaceutical companies  in their marketing activities are shown. All 
participants agree that pharmaceutical companies  pay attention to  ethics in their marketing activities. 
 
Table 6. Drug Sampling to Doctors as a Promoting Tool 
 
 
 
 
 
 
 
 
 
In Table 6, opinions on drug sampling to doctors are shown. Doctors, representatives and pharmacists agree with 
the statement, but company managers are undecided about it. 
 
Table 7. Consumption of Drug Samples 
 
Table 7 shows the opinions of the participants on the consumption of drug samples. Doctors and representatives 
agree with the statement, but company managers disagree with it. 
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companies  pay attention 
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Doctor 6,9 18,4 25,3 40,2 9,2 
M.Representative 7,9 11,9 23 46,8 10,3 
Pharmacist 1,4 20,8 27,8 45,8 4,2 
Company Manager - - 21,1 65,8 13,2 
Statement:  
 
Today one of the most 
effective promoting 
strategies is to do  drug 
sampling to doctors. 
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Doctor 2,3 19,5 19,5 49,4 9,2 
M.Representative 5,6 15,9 18,3 43,7 16,7 
Pharmacist 4,2 9,7 31,9 43,1 11,1 
Company Manager - 13,2 47,4 26,3 13,2 
Statement:  
 
All drug samples provided 
from pharmaceutical 
companies are consumed by 
the patient. 
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Doctor 1,1 28,7 19,5 32,2 18,4 
M.Representative 6,3 19 22,2 40,5 11,9 
Pharmacist 6,9 12,5 34,7 29,2 16,7 
Company Manager - 44,7 15,8 31,6 7,9 
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Table 8. Medical Training 
 
 
 
 
 
 
 
 
 
 
In Table 8, the necessity of medical training is shown. Doctors, representatives and pharmacists agree with the 
statement, but company managers strongly agree with it. 
 
Table 9. Promoting Activities 
 
 
 
 
 
 
 
 
 
 
In Table 9, the opinions on promoting activities which are continuous with medicine profession are shown. 
Doctors, representatives and pharmacists agree with the statement, but company managers disagree with it. 
 
Table 10. Social Networking and Blogs 
 
 
 
 
 
 
 
 
 
 
 
In Table 10, the opinions on social networking sites and blogs as effective promoting tools for  pharmaceutical 
companies are shown. As it is shown, doctors are undecided about it whereas representatives, pharmacists and 
company managers agree with the statement. 
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Doctor 1,1 3,4 19,5 47,1 28,7 
M.Representative 0,8 4,8 21,4 38,1 34,9 
Pharmacist 1,4 9,7 15,3 48,6 25 
Company Manager - - 5,3 21,1 73,7 
Statement: 
 
Pharmaceutical companies 
are increasingly giving more 
importance to promoting 
activities which are 
continuous with medicine 
profession.  
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Doctor 12,6 18,4 23 29,9 16,1 
M.Representative 6,3 15,9 31 37,3 9,5 
Pharmacist 5,6 15,3 33,7 35,7 9,7 
Company Manager 5,3 60,5 10,5 5,3 18,4 
Statement:  
 
Social networking sites and 
blogs are becoming an 
effective promoting tool 
for  pharmaceutical 
companies. 
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Doctor 1,1 16,1 35,6 33,3 13,8 
M.Representative 5,6 16,7 25,4 37,3 15,1 
Pharmacist 5,6 19,4 26,4 31,9 16,7 
Company Manager - 21,1 7,9 60,5 10,5 
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Table 11. Cause-related marketing 
 
 
 
 
 
 
 
 
 
 
In Table 11, the opinions on cause-related marketing are shown. As it is seen, doctors pharmacists and company 
managers agree with the statement. However, representatives disagree with it. 
Table 12. Public relations 
  
 
 
 
 
 
 
 
 
 
In Table 12, the opinions on public relations’ activities are shown. As it is seen, doctors pharmacists and 
representatives agree with the statement. However, company managers disagree with it. 
Table 13. Patient-centred marketing activities 
 
 
 
 
 
 
 
 
 
 
In Table 13, the opinions on patient-centred marketing activities as an alternative promoting tool are shown.  As 
it is seen, doctors pharmacists and representatives agree with the statement. However, company managers 
disagree with it. 
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marketing, financing 
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“economical health 
programs or providing 
disease awareness 
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effective promoting tool. 
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Doctor 1,1 14,9 35,6 42,5 5,7 
M.Representative 7,1 27,8 23,8 27 14,3 
Pharmacist 2,8 23,6 29,6 31,6 12,4 
Company Manager - 13,2 13,2 57,9 15,8 
Statement:  
 
Public relations is an 
effective promoting 
tool to reach the patient 
and doctors. 
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Doctor 3,4 10,3 25,3 50,6 10,3 
M.Representative 7,1 25,4 17,5 27,8 22,2 
Pharmacist 4,2 25 19,4 34,7 16,7 
Company Manager 7,9 44,7 18,4 23,7 5,3 
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are becoming an 
alternative promoting 
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Doctor 3,4 16,1 31 44,8 4,6 
M.Representative 7,1 22,2 27,8 29,4 13,5 
Pharmacist 5,6 26,4 18,1 38,9 11,1 
Company Manager 2,6 50 23,7 21,1 2,6 
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Table 14. Effects of partner relations 
 
 
 
 
 
 
 
 
 
 
In Table 14, the opinions on pharmaceutical companies working as partners (stakeholders) with supporter groups 
effect to their brand-value are shown.  As it is seen, all participants agree with the statement.  
Table 15. Effects of reliable product information 
 
 
 
 
 
 
 
 
 
 
In Table 15, the opinions on product information from a reliable resource affecting doctor’s dispensing are 
shown.  As it is seen, doctors strongly agree with the statement, but pharmacists, representatives and company 
managers agree with it.  
 
Table 16. Image resources 
 
 
 
 
 
 
 
 
 
 
In Table 16, the opinions on the image resources are shown.   As it is seen, doctors, representatives and company 
managers strongly agree with the statement, but pharmacists agree with it. 
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Doctor - 11,5 34,5 47,1 6,9 
M.Representative 3,2 10,3 20,6 49,2 16,7 
Pharmacist - 13,9 30,6 38,9 16,7 
Company Manager - 5,3 15,8 73,7 5,3 
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Doctor - 4,6 5,7 47,1 42,5 
M.Representative 1,6 0,8 7,9 46 43,7 
Pharmacist 1,4 1,4 9,7 52,8 34,7 
Company Manager 2,6 2,6 2,6 65,8 26,3 
Statement : 
 
The image on the 
doctor of the product 
and company is 
directly related to the 
honesty and 
professionality of the 
medical representative 
and company manager. 
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Doctor 1,1 1,1 8 39,1 50,6 
M.Representative 1,6 4 11,1 30,2 53,2 
Pharmacist - 6,9 9,7 43,1 40,3 
Company Manager - 2,6 - 18,4 78,9 
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Table 17. Doctors’ perceptions of company image 
 
 
 
 
 
 
 
 
 
 
In Table 17, the opinions on doctors’ perceptions of company image are shown.   As it is seen, doctors, 
pharmacists and company managers agree with the statement, but representatives strongly agree with it.  
 
5. Conclusion & Suggestions 
In pharmaceutical marketing, all stakeholders should serve to improve the sector creditably with a customer-
oriented perspective. It is seen that pharmaceutical companies are applying promotion activities increasingly to 
be more effective in today’s competitive environment. Effective and ethical promotion activities play a 
significant role in the development of company brand value. Moreover, reliable relations of stakeholders in the 
sector are necessary for the improvement of both the patient treatment processes and pharmaceutical companies. 
In this study, the promotion strategies in pharmaceutical marketing in terms of doctors, medical representatives, 
pharmacists and company managers working in four different cities in Turkey; the ethical aspect of these 
strategies; the effect of perceptions about pharmaceutical companies and their employees on the patient’s 
treatment process; the companies’ effect on the brand value are evaluated. 
The research findings show that; all stakeholders - doctors, medical representatives, pharmacists and company 
managers- pay attention to ethical rules in marketing activities, continuous medical training is important for all 
stakeholders, partnership of pharmaceutical companies with support groups is effective both in prescription and 
brand value processes, information from a reliable resource is positively effective in prescriptions, the image on 
the doctor of the product and company is related to the degree of honesty and professionality of the medical 
representative and company manager, doctors are generally influenced by the company image, and those 
findings show that there is a synergy among the stakeholders in the sector as well. 
Further research can be done with the other stakeholders in the sector such as customers, intermediates, etc.  
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